JO2129B1 - مركب غير مائي طارد لديدان الامعاء - Google Patents

مركب غير مائي طارد لديدان الامعاء

Info

Publication number
JO2129B1
JO2129B1 JO19992129A JOP19992129A JO2129B1 JO 2129 B1 JO2129 B1 JO 2129B1 JO 19992129 A JO19992129 A JO 19992129A JO P19992129 A JOP19992129 A JO P19992129A JO 2129 B1 JO2129 B1 JO 2129B1
Authority
JO
Jordan
Prior art keywords
non aqueous
anthelmintic composition
composition
anthelmintic
milb
Prior art date
Application number
JO19992129A
Other languages
English (en)
Inventor
دافي سين
كرومي لليانا
Original Assignee
نوربروك لابوراتوريز ليمتد
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by نوربروك لابوراتوريز ليمتد filed Critical نوربروك لابوراتوريز ليمتد
Application granted granted Critical
Publication of JO2129B1 publication Critical patent/JO2129B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

طريقة لتحضير مستحضر بيطري، لمقاومة الطفيليات الباطنية والطفيليات الخارجية، وتعطي جانب محسن ‏للحركية الدوائية، وهذه الطريقة تتضمن اعطاء مادة مبيدة للطفيليات مثل الافرمكتين بصفة خاصة الايفرمكتين، او ‏الميلبميسين، بكمية من حوالي 0.1% وزن / حجم حتى 20% وزن – حجم، مذابة في نظام مذيب محتوى على ‏اكثر من حوالى 75% حجم / حجم من بولي اثيلين الجليكول وبما لا يقل عن حوالي 25% حجم/ حجم من ‏الجليسرول الاساسي.‏
JO19992129A 1998-07-24 1999-07-20 مركب غير مائي طارد لديدان الامعاء JO2129B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9816132.6A GB9816132D0 (en) 1998-07-24 1998-07-24 Non-aqueous anthelmintic composition

Publications (1)

Publication Number Publication Date
JO2129B1 true JO2129B1 (ar) 2002-08-07

Family

ID=10836088

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19992129A JO2129B1 (ar) 1998-07-24 1999-07-20 مركب غير مائي طارد لديدان الامعاء

Country Status (9)

Country Link
AR (1) AR020613A1 (ar)
AU (1) AU5054099A (ar)
CO (1) CO5070578A1 (ar)
DZ (1) DZ2853A1 (ar)
GB (2) GB9816132D0 (ar)
JO (1) JO2129B1 (ar)
PE (1) PE20001064A1 (ar)
UY (1) UY25622A1 (ar)
WO (1) WO2000004906A1 (ar)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733095B3 (en) * 1999-09-22 2001-05-03 Ashmont Holdings Limited Sheep pour on
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US12485133B2 (en) 2021-02-04 2025-12-02 Hovione Scientia Limited Inhaled ivermectin
CN115399316B (zh) * 2022-09-15 2025-02-11 湖北省农业科学院植保土肥研究所 一种农药桶混助剂组合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210505A (en) * 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
AU736398B2 (en) * 1996-10-25 2001-07-26 Chemvet (Nz) Limited Anthelmintic formulation

Also Published As

Publication number Publication date
UY25622A1 (es) 2000-02-23
CO5070578A1 (es) 2001-08-28
WO2000004906A1 (en) 2000-02-03
DZ2853A1 (fr) 2003-12-01
AR020613A1 (es) 2002-05-22
PE20001064A1 (es) 2000-10-11
GB9915531D0 (en) 1999-09-01
AU5054099A (en) 2000-02-14
GB2339691A (en) 2000-02-09
GB9816132D0 (en) 1998-09-23

Similar Documents

Publication Publication Date Title
UY25806A1 (es) Formulaciones antiparasitarias que contienen avermectinas o milbemicinas.
MXPA05010659A (es) Formulaciones veterinarias antihelminticas topicas.
CY1120513T1 (el) Υψηλης συμπυκνωσης συνθεση μινοξιδιλης
EP0971705A4 (en) MEDICINE FORMULATIONS FOR HORMONE REPLACEMENT THERAPY FOR TOPICAL APPLICATION ON THE SKIN
AU3357800A (en) Method of preparing alkylated salicylamides
MX9703429A (es) Composiciones hermorroidales y metodos de uso.
ATE300283T1 (de) Propofol-formulierung
TR199802700T2 (xx) Ha�ere �ld�r�c� bile�imler.
WO2000007979A3 (en) Compounds and compositions for delivering active agents
TR200103235T2 (tr) Organ tutma, koruma ve saklama.
EP1060732A3 (en) Novel topical formulations comprising vesicle delivery systems
TW565461B (en) Immunosuppressive pharmaceutical composition for external application
NZ210505A (en) Parasiticidal compositions containing avermectin or milbemycin derivatives
ATE275974T1 (de) Zusammensetzungen enthaltend glykolderivate, alkohole und vitamin d
AR021370A1 (es) Composiciones farmaceuticas inyectables estabilizadas que contienen agentes anti-neoplasicos taxoides
GB2329585A (en) A barrier cream comprising hexamethylenetetramine or derivative thereo
IL131128A0 (en) Nimesulide gel systems for topical use
JO2129B1 (ar) مركب غير مائي طارد لديدان الامعاء
GB9801109D0 (en) Cyclodextrin compositions
HUP0203847A3 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants, process for their preparation and pharmaceutical compositions containing them
ATE223221T1 (de) Lösliche arzneizusammensetzungen enthaltend 2- chloro-2'-deoxyadenosine
WO2005023175A3 (en) Stable pharmaceutical composition of fluoroether compound for anesthetic use, method for stabilizing a fluoroether compound, use of stabilizer agent for precluding the degradation of a fluoroether compound
DE69923835D1 (de) Makrolid-lhrh-antagonisten
TR200002766T2 (tr) 3',3'-N-Bis-ikameli makrolit LHRH Antagonistleri
WO2003040316A3 (en) Selective elimination of cd52+ cells and uses thereof